Aarey Drugs & Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis
AAREYDRUGS
Pharmaceuticals
Screen Aarey Drugs & Pharmaceuticals share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹69.37
▲
1.52 (2.24%)
Share Price BSE
₹69.65
▲
2.79 (4.17%)
Market Cap
₹198.05 Cr.
P/E Ratio (TTM)
52.65
P/B Ratio
1.30
EPS (TTM)
₹1.42
Dividend Yield
-
Debt to Equity
0.24
52W High
₹72.30
52W Low
₹65.28
Operating Margin
1.00%
Profit Margin
0.91%
Revenue (TTM)
₹439.00
EBITDA
₹13.00
Net Income
₹4.00
Total Assets
₹291.00
Total Equity
₹139.00
Aarey Drugs & Pharmaceuticals Share Price History - Stock Screener Chart
Screen AAREYDRUGS historical share price movements with interactive charts. Analyze price trends and patterns.
Aarey Drugs & Pharmaceuticals Company Profile - Fundamental Screener
Screen Aarey Drugs & Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AAREYDRUGS shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE198H01019
Aarey Drugs & Pharmaceuticals Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen AAREYDRUGS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 291 | 303 | 291 | 245 | 233 | 194 | 146 | 170 | 143 | 125 |
| Current Assets | 266 | 283 | 271 | 219 | 218 | 181 | 133 | 157 | 130 | 117 |
| Fixed Assets | 16 | 13 | 14 | 15 | 14 | 12 | 12 | 12 | 12 | 8 |
| Liabilities | ||||||||||
| Total Liabilities | 291 | 303 | 291 | 245 | 233 | 194 | 146 | 170 | 143 | 125 |
| Current Liabilities | 3 | 4 | 6 | 5 | 3 | 2 | 2 | 1 | 2 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 139 | 133 | 117 | 114 | 99 | 92 | 87 | 80 | 49 | 37 |
| Share Capital | 29 | 28 | 25 | 25 | 23 | 23 | 23 | 23 | 18 | 17 |
| Reserves & Surplus | 105 | 100 | 87 | 86 | 73 | 67 | 61 | 55 | 30 | 20 |
Screen AAREYDRUGS income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 439 | 484 | 403 | 422 | 495 | 355 | 307 | 359 | 353 | 399 | 249 | 216 |
| Expenses | 426 | 471 | 391 | 411 | 481 | 344 | 297 | 347 | 342 | 386 | 245 | 212 |
| EBITDA | 13 | 13 | 11 | 11 | 14 | 12 | 10 | 12 | 11 | 13 | 4 | 4 |
| Operating Profit % | 1.00% | 1.00% | 1.00% | 2.00% | 2.00% | 1.00% | 1.00% | 2.00% | 2.00% | 2.00% | 0.00% | 1.00% |
| Depreciation | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 4 | 5 | 4 | 3 | 2 | 2 | 2 | 2 | 2 | 4 | 2 | 2 |
| Profit Before Tax | 6 | 6 | 5 | 6 | 10 | 8 | 7 | 9 | 8 | 8 | 2 | 1 |
| Tax | 2 | 2 | 1 | 2 | 4 | 2 | 1 | 2 | 2 | 3 | 1 | 0 |
| Net Profit | 4 | 4 | 5 | 4 | 7 | 7 | 6 | 7 | 6 | 6 | 1 | 1 |
| EPS | 1.30 | 1.42 | 1.84 | 1.49 | 2.72 | 2.79 | 2.48 | 2.80 | 2.64 | 3.03 | 0.77 | 0.65 |
Aarey Drugs & Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen AAREYDRUGS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 10 | -3 | -1 | 1 | 6 | 3 | 1 | -20 | 1 | 6 |
| Investing Activities | -6 | -2 | 0 | -3 | -3 | -1 | -1 | -1 | -5 | -3 |
| Financing Activities | -5 | 6 | 1 | 2 | -3 | -2 | -3 | 23 | 4 | -2 |
| Net Cash Flow | 0 | 1 | 1 | -1 | 0 | 0 | -3 | 2 | -1 | 2 |
Screen AAREYDRUGS shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 44.80% | 44.80% | 44.80% | 44.80% | 45.44% | 45.28% | 45.28% | 50.04% |
| FII Holding | 1.13% | 1.97% | 2.34% | 2.34% | 2.75% | 3.40% | 3.40% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 47.01% | 46.60% | 45.79% | 44.87% | 47.56% | 44.51% | 47.14% | 42.24% |
| Other Holding | 7.06% | 6.63% | 7.07% | 7.99% | 4.25% | 6.82% | 4.18% | 7.72% |
| Shareholder Count | 14,897 | 15,796 | 16,257 | 16,288 | 16,676 | 16,179 | 16,821 | 17,699 |
Aarey Drugs & Pharmaceuticals Dividend Screener - Share Yield Analysis
Screen AAREYDRUGS dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Aarey Drugs & Pharmaceuticals Index Membership - Market Screener Classification
Screen AAREYDRUGS by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Aarey Drugs & Pharmaceuticals Market Events Screener - Corporate Actions
Screen AAREYDRUGS market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -0.82% | ||
| Annual General Meeting | NA | 11.95% | ||
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -2.10% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -3.93% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 0.96% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -3.23% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -9.71% |
| 2023-12-29 | 2023-12-29 | Extraordinary General Meeting | NA | 10.20% |
| 2023-12-29 | 2023-12-29 | Annual General Meeting | NA | 10.20% |
Aarey Drugs & Pharmaceuticals Competitors Screener - Peer Comparison
Screen AAREYDRUGS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 427,705 | 40.28 | 54,729 | 9.71% | 10,980 | 58.99 |
| Divis Laboratories | 176,338 | 70.98 | 9,712 | 18.67% | 2,191 | 63.15 |
| Torrent Pharmaceuticals | 138,499 | 62.26 | 11,539 | 6.99% | 1,911 | 80.95 |
| Cipla | 118,573 | 22.75 | 28,410 | 7.12% | 5,291 | 38.52 |
| Dr Reddys Laboratories | 103,728 | 18.27 | 33,741 | 16.73% | 5,725 | 40.17 |
| Lupin | 101,149 | 22.61 | 22,910 | 13.74% | 3,306 | 71.67 |
| Mankind Pharma | 95,432 | 52.17 | 12,744 | 20.90% | 2,007 | 64.16 |
| Zydus Life Science | 93,333 | 18.63 | 23,511 | 18.55% | 4,615 | 52.14 |
| Aurobindo Pharma | 71,752 | 20.91 | 32,346 | 9.43% | 3,484 | 61.25 |
| Alkem Laboratories | 69,425 | 28.04 | 13,458 | 3.70% | 2,216 | 63.97 |
Aarey Drugs & Pharmaceuticals Company Announcements - News Screener
Screen AAREYDRUGS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-02 | Closure of Trading Window | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-13 | Unaudited Financial Results For The Quarter & Half Year Ended On 30Th Sept 2025 | View |
| 2025-11-13 | Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th November 2025 | View |
| 2025-11-08 | Board Meeting Intimation for Intimation Of Board Meeting. | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-29 | Closure of Trading Window | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-24 | Corrigendum To The Integrated Annual Report For FY 2024-25 | View |
| 2025-09-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-06 | Reg. 34 (1) Annual Report. | View |
| 2025-09-06 | Notice Of 35Th Annual General Meeting Of The Company For The Financial Year 2024-25 | View |
| 2025-09-06 | Intimation Of Book Closure | View |
| 2025-09-04 | Revised Outcome Of Board Meeting Held On 03Rd September 2025 | View |
| 2025-09-03 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-03 | Board Meeting Outcome for Outcome Of Board Meeting Held On 03" September 2025 | View |
| 2025-08-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-13 | Unaudited Financial Results For The Quarter Ended 30Th June 2025 Along With The Limited Review Report MD/CFO Certification. | View |
| 2025-08-13 | Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E 13Th August 2025 | View |